Our Journey from humble beginnings
to our proud heritage, Our story began in 1968.


Prime Group starts as an API company in Kolkata.


Enters the African Markets. & South East Asian Markets.


Invested in an EU- compliant bio-similar facility. Expanded global footprint to 50 + countries. Established office in Europe to facilitate partnerships within the EU. Enters the Latin & Central American Markets.


Sets up offices in Costa Rica, Spain, UAE & USA


Established a joint venture in Tanzania for business development and marketing in East Africa. Invested in an EU-compliant greenfield facility. Attained control of an Algerian company with two manufacturing plants


Successful clinical trials for two bio-similar products. Initiated the setup of a diagnostic chain in Tanzania. Commenced the filing process for products in the EU. Triggered EMA audit for OSD and Bio-similar Facilities.

Moving Forward

We are on a path of expansion which is reflected through our acquisition of a manufacturing facility in Gujarat and completion of our biosimilar facility in Chennai. Commercialization of the biosimilar range is expected in Q3 2022. Additionally, we have now opened three new offices in Spain, UAE, and Costa Rica in order to expand our reach and range in the regions.

Let's Improve Healthcare Together

Prime Pharmaceuticals Pvt. Ltd

B327/328, 3rd Floor,
Chintamani Plaza,
Andheri Kurla Road,
Andheri (East),
Mumbai 400099, INDIA.